Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R33MH111850-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
Not provided
Not provided
Not provided
Not provided
Young people who are at great risk for developing psychosis have cognitive deficits which are strongly related to functioning in the community. This study looks to target a specific cognitive skill called processing speed to see if improving the ability to process information in a timely manner will improve social function in adolescents and young adults at risk for developing schizophrenia. Half will receive neurofeedback cognitive training targeting processing speed while the other half will receive an active control.
Processing speed deficits are characteristic of schizophrenia and related to its functional impairment, including in its nascent stages, during a putatively prodromal or clinical high risk period. These cognitive deficits have proven relatively refractory to pharmacologic strategies, though the deficits can be improved with cognitive remediation programs in schizophrenia. The cognitive gains can then generalize to functional improvement, particularly early in the course of illness (i.e. first episode psychosis). Although processing speed deficits are also prevalent in young people identified as at clinical high risk for psychosis (i.e. "psychosis risk syndrome"), and related to their concurrent impaired function and predictive of later psychosis (onset of which occurs in 20-25% of clinical high risk cohorts), little research has focused on how to remediate these deficits in clinical high risk patients. Remediating core cognitive deficits in clinical high risk patients could plausibly address present functional impairment in these young people and moderate illness progression. The investigators propose to conduct a double-blind randomized trial in 105 clinical high risk patients to examine a focal processing speed training program versus an active control in terms of improvement in processing speed and social function, and reduction in prodromal symptom severity.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Processing speed training | Experimental | Neurofeedback processing speed training |
|
| Active control | Active Comparator | Computer games |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neurofeedback processing speed training | Behavioral | Processing speed training on tablets that incorporates changes in pupil size to titrate the learning algorithm |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change on the Wechsler Intelligence Scale Processing Speed Index | Change on a paper and pencil test of processing speed | Baseline, 1 month, 2 month, 6 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Connecting Adolescents with Psychosis (CAP), Child & Adolescents Day Program | Hartford | Connecticut | 06106 | United States | ||
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jun 6, 2024 | |
| Reset | Jul 1, 2024 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jun 6, 2024 | Jul 1, 2024 |
| ID | Term |
|---|---|
| D012569 | Schizotypal Personality Disorder |
| D012917 | Social Adjustment |
| ID | Term |
|---|---|
| D010554 | Personality Disorders |
| D001523 | Mental Disorders |
| D012919 | Social Behavior |
| D001519 | Behavior |
Not provided
Not provided
Randomized controlled trial with intervention versus active control
Not provided
Not provided
Double blind
| Active control | Behavioral | Commercially available games on tablet |
|
| Olin Neuropsychiatry Research Center |
| Hartford |
| Connecticut |
| 06106 |
| United States |